Rivian Automotive Valuation
Is RIVN * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of RIVN * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate RIVN *'s fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate RIVN *'s fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for RIVN *?
Other financial metrics that can be useful for relative valuation.
What is RIVN *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$11.90b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.8x |
Enterprise Value/EBITDA | -1.9x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does RIVN *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 3.2x | ||
FROTO Ford Otomotiv Sanayi | 0.9x | 23.8% | ₺392.7b |
LCID Lucid Group | 9.3x | 42.0% | US$5.9b |
LI Li Auto | 1.1x | 20.5% | US$19.6b |
TOASO Tofas Türk Otomobil Fabrikasi Anonim Sirketi | 1.3x | 20.7% | ₺171.5b |
RIVN * Rivian Automotive | 2.9x | 32.9% | Mex$11.9b |
Price-To-Sales vs Peers: RIVN * is good value based on its Price-To-Sales Ratio (2.9x) compared to the peer average (3.3x).
Price to Earnings Ratio vs Industry
How does RIVN *'s PE Ratio compare vs other companies in the Global Auto Industry?
Price-To-Sales vs Industry: RIVN * is expensive based on its Price-To-Sales Ratio (2.9x) compared to the Global Auto industry average (0.9x).
Price to Sales Ratio vs Fair Ratio
What is RIVN *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 2.9x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate RIVN *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$268.66 | Mex$298.47 +11.1% | 35.8% | Mex$660.71 | Mex$183.53 | n/a | 27 |
Jun ’25 | Mex$183.73 | Mex$253.94 +38.2% | 38.1% | Mex$604.80 | Mex$168.00 | n/a | 25 |
May ’25 | Mex$153.36 | Mex$279.65 +82.3% | 36.4% | Mex$612.64 | Mex$153.16 | n/a | 27 |
Apr ’25 | Mex$184.98 | Mex$297.69 +60.9% | 32.9% | Mex$600.72 | Mex$150.18 | n/a | 27 |
Mar ’25 | Mex$194.95 | Mex$313.40 +60.8% | 32.8% | Mex$612.67 | Mex$136.15 | n/a | 26 |
Feb ’25 | Mex$265.00 | Mex$426.45 +60.9% | 24.2% | Mex$683.46 | Mex$256.30 | n/a | 24 |
Jan ’25 | Mex$398.25 | Mex$452.73 +13.7% | 21.8% | Mex$691.39 | Mex$259.27 | n/a | 26 |
Dec ’24 | Mex$310.00 | Mex$454.63 +46.7% | 21.1% | Mex$684.68 | Mex$256.76 | n/a | 25 |
Nov ’24 | Mex$287.08 | Mex$515.23 +79.5% | 22.6% | Mex$804.86 | Mex$274.38 | n/a | 24 |
Oct ’24 | Mex$424.38 | Mex$491.61 +15.8% | 21.4% | Mex$754.56 | Mex$257.24 | n/a | 24 |
Sep ’24 | Mex$398.50 | Mex$490.52 +23.1% | 21.7% | Mex$749.87 | Mex$255.64 | n/a | 23 |
Aug ’24 | Mex$462.00 | Mex$439.86 -4.8% | 27.9% | Mex$674.45 | Mex$236.06 | n/a | 23 |
Jul ’24 | Mex$284.64 | Mex$392.70 +38.0% | 32.8% | Mex$688.40 | Mex$189.31 | n/a | 22 |
Jun ’24 | Mex$262.39 | Mex$423.81 +61.5% | 35.3% | Mex$715.83 | Mex$196.85 | Mex$183.73 | 22 |
May ’24 | Mex$235.74 | Mex$481.27 +104.2% | 42.3% | Mex$1,042.62 | Mex$251.67 | Mex$153.36 | 22 |
Apr ’24 | Mex$278.94 | Mex$582.48 +108.8% | 38.9% | Mex$1,165.83 | Mex$296.08 | Mex$184.98 | 21 |
Mar ’24 | Mex$286.82 | Mex$589.64 +105.6% | 38.8% | Mex$1,140.48 | Mex$289.65 | Mex$194.95 | 21 |
Feb ’24 | Mex$370.00 | Mex$730.61 +97.5% | 33.7% | Mex$1,183.40 | Mex$356.90 | Mex$265.00 | 19 |
Jan ’24 | Mex$355.99 | Mex$896.88 +151.9% | 28.0% | Mex$1,383.82 | Mex$454.68 | Mex$398.25 | 19 |
Dec ’23 | Mex$603.00 | Mex$905.09 +50.1% | 27.2% | Mex$1,346.41 | Mex$442.39 | Mex$310.00 | 18 |
Nov ’23 | Mex$660.06 | Mex$1,041.79 +57.8% | 28.0% | Mex$1,653.50 | Mex$537.89 | Mex$287.08 | 17 |
Oct ’23 | Mex$690.00 | Mex$1,059.42 +53.5% | 27.3% | Mex$1,670.21 | Mex$543.32 | Mex$424.38 | 17 |
Sep ’23 | Mex$625.00 | Mex$1,045.38 +67.3% | 29.1% | Mex$1,646.82 | Mex$535.71 | Mex$398.50 | 16 |
Aug ’23 | Mex$693.25 | Mex$1,088.90 +57.1% | 40.6% | Mex$2,216.11 | Mex$492.47 | Mex$462.00 | 15 |
Jul ’23 | Mex$522.00 | Mex$1,015.94 +94.6% | 48.3% | Mex$2,174.14 | Mex$483.14 | Mex$284.64 | 15 |
Jun ’23 | Mex$601.00 | Mex$1,138.17 +89.4% | 56.5% | Mex$2,896.41 | Mex$472.88 | Mex$262.39 | 17 |
Analyst Forecast: Target price is less than 20% higher than the current share price.